GlobeStar Therapeutics GSTC Stock
GlobeStar Therapeutics Price Chart
GlobeStar Therapeutics GSTC Financial and Trading Overview
| GlobeStar Therapeutics stock price | 0.0007 USD |
| Previous Close | 0.0058 USD |
| Open | 0.0061 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0048 - 0.0061 USD |
| 52 Week Range | 0.0025 - 0.02 USD |
| Volume | 2.13M USD |
| Avg. Volume | 2.4M USD |
| Market Cap | 3.94M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GSTC Valuation Measures
| Enterprise Value | 4.66M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.02 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
GlobeStar Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 28.20% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.02 USD |
| 52 Week Low | 0.0025 USD |
| 50-Day Moving Average | 0.005116 USD |
| 200-Day Moving Average | 0.0071575 USD |
GSTC Share Statistics
| Avg. Volume (3 month) | 2.4M USD |
| Avg. Daily Volume (10-Days) | 4.58M USD |
| Shares Outstanding | 787.69M |
| Float | 699.79M |
| Short Ratio | N/A |
| % Held by Insiders | 10.94% |
| % Held by Institutions | 0.021% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | September 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -121968.35% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -782557 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 176 USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 89.1K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0 |
| Book Value Per Share (mrq) | -0.002 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -179500 USD |
| Levered Free Cash Flow (ttm) | 527.95K USD |
Profile of GlobeStar Therapeutics
| Country | United States |
| State | WA |
| City | Richland |
| Address | 719 Jadewin Avenue |
| ZIP | 99352 |
| Phone | 206 451 1970 |
| Website | N/A |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. The company was incorporated in 2016 and is headquartered in Richland, Washington.
Q&A For GlobeStar Therapeutics Stock
What is a current GSTC stock price?
GlobeStar Therapeutics GSTC stock price today per share is 0.0007 USD.
How to purchase GlobeStar Therapeutics stock?
You can buy GSTC shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GlobeStar Therapeutics?
The stock symbol or ticker of GlobeStar Therapeutics is GSTC.
Which industry does the GlobeStar Therapeutics company belong to?
The GlobeStar Therapeutics industry is Biotechnology.
How many shares does GlobeStar Therapeutics have in circulation?
The max supply of GlobeStar Therapeutics shares is 1.08B.
What is GlobeStar Therapeutics Price to Earnings Ratio (PE Ratio)?
GlobeStar Therapeutics PE Ratio is now.
What was GlobeStar Therapeutics earnings per share over the trailing 12 months (TTM)?
GlobeStar Therapeutics EPS is 0 USD over the trailing 12 months.
Which sector does the GlobeStar Therapeutics company belong to?
The GlobeStar Therapeutics sector is Healthcare.